A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00654758 · COMPLETED
Trial details
- NCT number
- NCT00654758
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-05-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.